HealthStream (NASDAQ: HSTM) reported Q4 EPS of $0.09, $0.04 better than the analyst estimate of $0.05. Revenue for the quarter came in at $59.8 million versus the consensus estimate of $58.92 million.

• Revenues of $59.8 million in the fourth quarter of 2018, up 8% from $55.3 million in the fourth quarter of 2017 with $342,000 negative impact in the fourth quarter of 2018 from the application of ASC 606
• Operating income of $2.8 million in the fourth quarter of 2018, up 88% from $1.5 million in the fourth quarter of 2017 with $897,000 positive impact in the fourth quarter of 2018 from the application of ASC 606
• Income from continuing operations of $2.9 million in the fourth quarter of 2018, down 8% from $3.2 million in the fourth quarter of 2017 with $877,000 positive impact in the fourth quarter of 2018 from the application of ASC 606
• Earnings per share (EPS) from continuing operations of $0.09 per share (diluted) in the fourth quarter of 2018, compared to $0.10 per share (diluted) in the fourth quarter of 2017
• Adjusted EBITDA1 from continuing operations of $9.5 million in the fourth quarter of 2018, up 16% from $8.2 million in the fourth quarter of 2017 with $897,000 positive impact in the fourth quarter of 2018 from the application of ASC 606

“Our full-year 2018 financial results reflect a year of solid performance over the prior year with revenues up 8 percent, operating income up 65 percent, and adjusted EBITDA up 18 percent to $41.5 million,” said Robert A. Frist, Jr., Chief Executive Officer, HealthStream. “Our performance positions us well to make investments for long-term growth. Already in 2019, we have invested in new senior leadership, launched major new products, and made a strategic acquisition—all which place us on a growth offensive.”

GUIDANCE:

HealthStream sees FY2019 revenue of $251-258 million, versus the consensus of $241.67 million.

For earnings history and earnings-related data on HealthStream (HSTM) click here.